1 / 3

What is the Multiple Sclerosis?

Multiple Sclerosis (MS) is an unpredictable, autoimmune disease that affects the central nervous system. In multiple sclerosis, the bodyu2019s own immune system produces cells and proteins (antibodies) that attack the fatty substance, myelin, which is responsible for protecting the nerve fibers. This is often characterized by relapsing episodes of neurologic impairment followed by remissions.<br><br>https://www.delveinsight.com/infographics/multiple-sclerosis-market?utm_source=marketing&utm_medium=promotion&utm_campaign=infographic

yashb
Download Presentation

What is the Multiple Sclerosis?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What is the Multiple Sclerosis? Multiple Sclerosis (MS) is an unpredictable, autoimmune disease that affects the central nervous system. In multiple sclerosis, the body’s own immune system produces cells and proteins (antibodies) that attack the fatty substance, myelin, which is responsible for protecting the nerve fibers. This is often characterized by relapsing episodes of neurologic impairment followed by remissions. Multiple Sclerosis Epidemiology Segmentation in the 7MM Prevalence of Multiple Sclerosis based on Gender Total Prevalent Cases of Multiple Sclerosis Phenotype-specific prevalent cases of Multiple Sclerosis Prevalence of Multiple Sclerosis based on Age Expanded Disability Status Scale Multiple Sclerosis Epidemiological Insights Observed in the 7MM (2020) The total prevalent cases of Multiple Sclerosis in the 7MM were found to be 1.2 million in the year 2020. Multiple Sclerosis Market Insight The market size of Multiple Sclerosis in the 7MM was found to be almost USD 22,381 million in 2020. Multiple Sclerosis Market Drivers Increasing population with Multiple Sclerosis Extensively approved therapies Wide range of R&D pipelines Increasing awareness Multiple Sclerosis Market Barriers High cost of drugs High incidence of adverse events

  2. Patent expiration Multiple Sclerosis Emerging Therapies The emerging drugs in the Multiple Sclerosis market are NeuroVax CNM-Au8 Tolebrutinib Evobrutinib/M2951 Ublituximab, and others Multiple Sclerosis Market Companies The key players working in the Multiple Sclerosis market are Immune Response BioPharma, Inc Clene Nanomedicine Sanofi Merck Healthcare KGaA TG Therapeutics, Inc., and several others About Us DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions. Contact Us Yash info@delveinsight.com

More Related